The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented...
Read More Details
Finally We wish PressBee provided you with enough information of ( Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance )
Also on site :
- The Real Seal Expands Community Outreach with Free Basement Waterproofing Inspections for Chicago Residents
- Trump threatens 25% tariffs on iPhones and 50% levies against Europe, quickly tanking stocks
- Международный день биологического разнообразия 2025 года: Shanghai Electric отмечает глобальные усилия по защите биоразнообразия, призывая к гармонии с природой